NEW YORK CITY, NY / ACCESS Newswire / August 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elevance Health, Inc. ("Elevance" or "the Company") (NYSE:ELV). Investors who purchased Elevance securities prior to April 18, 2024, and continue to hold to the present, are encouraged to obtain […]

NEW YORK CITY, NY / ACCESS Newswire / August 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fluor Corporation ("Fluor" or "the Company") (NYSE:FLR). Investors who purchased Fluor securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/FLR. Investigation

NEW YORK CITY, NY / ACCESS Newswire / August 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pacira BioSciences, Inc. ("Pacira" or "the Company") (NASDAQ:PCRA). Investors who purchased Pacira securities prior to August 2, 2023, and continue to hold to the present, are encouraged to obtain

NEW YORK CITY, NY / ACCESS Newswire / August 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of TransMedics Group, Inc. ("TransMedics" or "the Company") (NASDAQ:TMDX). Investors who purchased TransMedics securities prior to February 3, 2022, and continue to hold to the present, are encouraged to obtain

(NASDAQ:NEO), NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether NeoGenomics and certain of its officers and/or directors have engaged

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of NeoGenomics, Inc. – NEO GlobeNewswire August 17, 2025 NEW YORK, Aug. 17, 2025 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors of NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO). Such investors are advised to contact Danielle Peyton at

NEW YORK, NY / ACCESS Newswire / August 17, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Fortinet, Inc. ("Fortinet, Inc.") (NYSE:FTNT) concerning possible violations of federal securities laws. Fortinet reported its Q2 financial results on August 6, 2025. Investor’s Business Daily quotes William Blair analyst Jonathan Ho as

NEW YORK, NY / ACCESS Newswire / August 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of LifeMD, Inc. ("LifeMD" or "the Company") (NASDAQ:LFMD). Investors who purchased LifeMD securities are encouraged to obtain additional information and assist the investigation by visiting the firm’s site: bgandg.com/LFMD. Investigation Details

NEW YORK CITY, NY / ACCESS Newswire / August 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Nextracker Inc. ("Nextracker" or "the Company") (NASDAQ:NXT). Investors who purchased Nextracker securities prior to February 1, 2024, and continue to hold to the present, are encouraged to obtain additional

NEW YORK CITY, NY / ACCESS Newswire / August 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Paragon 28, Inc. ("Paragon 28" or "the Company") (NYSE:FNA). Investors who purchased Paragon 28 securities prior to May 5, 2023, and continue to hold to the present, are encouraged